Login / Signup
Toward Inclusive Oncology: Challenges in the Therapy of Pediatric Non-B Non-Hodgkin Lymphomas.
Joanna Stankiewicz
Anna Jabłońska
Paweł Treichel
Jan Styczyński
Published in:
In vivo (Athens, Greece) (2024)
There is a lack of knowledge on optimal therapeutic strategies for rare NHLs. It is crucial to create trials dedicated to uncommon NHLs and establish therapy guidelines for these patients.
Keyphrases
</>
end stage renal disease
newly diagnosed
ejection fraction
healthcare
prognostic factors
palliative care
stem cells
clinical practice
hodgkin lymphoma
bone marrow
cell therapy